Background Globally lung cancer is one of the most common cancers, and is responsible for
almost 20% of all cancer care costs. As a potential treatment for lung cancer, anti-PD-1/PD …

e20562 Background: The study was designed to explore the evolution of non-small cell lung
cancer (NSCLC) management in the 21st century. Methods: The top 100 most-cited papers …

Background: Bibliometrics has been used for assessing and predicting trends in macro-
health science and medical systems, especially in the field of cancer. Bibliometric and …

Objective The study was designed to explore the evolution of non-small cell lung cancer
(NSCLC) management in the last 20 years. Methods The top 100 most-cited papers on …

Objective To gain a deeper understanding of the hot topics and future prospects of
programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) inhibitors …

Objectives The study aims to summarize publication characteristics of anti-programmed cell
death protein 1 (PD-1)/programmed cell death 1 ligand 1 (PD-L1) immunotherapy for …

​ Background Immunotherapy for lung cancer has been a hot research area for years. This
bibliometric analysis aims to present the research trends on lung cancer immunotherapy …

Results A total of 240,701 eligible articles were identified and we chose the top 100 articles
cited in the field of lung cancer. The mean number of citations for these articles was …

Objectives To identify the cooperation of authors, countries, and institutions and explore the
hot topics and future prospects regarding programmed cell death protein 1 (PD-1) and …

Background This paper aims to show the scientific research and technological development
trends of antineoplastics targeting PD-1/PD-L1 based on scientometrics and patentometrics …